Hypothalamic DBS therapy improves recovery of lower limb movements after spinal cord injury

Researchers at EPFL and Lausanne University Hospital (CHUV), led by professors Grégoire Courtine and Jocelyne Bloch, have achieved a major milestone in the treatment of spinal cord injuries (SCI).

Lilly, Eisai and Biogen seek more specifics in FDA guidance on early Alzheimer’s disease

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 13, 2024

Natural Medicine Advisory Bulletin 10.1: Legislative Update – Psychedelic Alpha

On April 4, 2024, the Colorado General Assembly introduced Senate Bill 24-198, the first legislative update since the passing of SB 23-290 in 2023, which

April 9, 2024

AEVIS VICTORIA SA – Publication of the half-year report 2023 – Biotech Investments

AEVIS VICTORIA SA / Key word(s): Half Year Results 14-Sep-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The

September 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.